相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study
D. Romualdi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2013)
The effect of obesity and low-dose oral contraceptives on carbohydrate and lipid metabolism
Anitra Beasley et al.
CONTRACEPTION (2012)
Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome
Sudhindra Mohan Bhattacharya et al.
FERTILITY AND STERILITY (2012)
Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study
T. Piltonen et al.
HUMAN REPRODUCTION (2012)
Oral contraceptives in polycystic ovary syndrome: Risk-benefit assessment
Bulent O. Yildiz
SEMINARS IN REPRODUCTIVE MEDICINE (2008)
Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism
Cem Batukan et al.
GYNECOLOGICAL ENDOCRINOLOGY (2007)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Exogenous sex hormones and thrombophilia
Isobel D. Walker
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2006)
Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis
JP Baillargeon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism
C Klipping et al.
CONTRACEPTION (2005)
Polycystic ovary syndrome in adolescence - a therapeutic conundrum
R Homburg et al.
HUMAN REPRODUCTION (2004)
A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles
U Gaspard et al.
CONTRACEPTION (2004)
Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome
J Vrbíkoná et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
An observational study of Yasmin® in the management of women with polycystic ovary syndrome
M Palep-Singh et al.
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE (2004)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
BCJM Fauser et al.
HUMAN REPRODUCTION (2004)
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism
U Gaspard et al.
CONTRACEPTION (2003)
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins
I Wiegratz et al.
CONTRACEPTION (2003)